Literature DB >> 23059829

A generalisation of T-optimality for discriminating between competing models with an application to pharmacokinetic studies.

Pavan Vajjah1, Stephen B Duffull.   

Abstract

The T-optimality criterion is used in optimal design to derive designs for model selection. To set up the method, it is required that one of the models is considered to be true. We term this local T-optimality. In this work, we propose a generalisation of T-optimality (termed robust T-optimality) that relaxes the requirement that one of the candidate models is set as true. We then show an application to a nonlinear mixed effects model with two candidate non-nested models and combine robust T-optimality with robust D-optimality. Optimal design under local T-optimality was found to provide adequate power when the a priori assumed true model was the true model but poor power if the a priori assumed true model was not the true model. The robust T-optimality method provided adequate power irrespective of which model was true. The robust T-optimality method appears to have useful properties for nonlinear models, where both the parameter values and model structure are required to be known a priori, and the most likely model that would be applied to any new experiment is not known with certainty.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Year:  2012        PMID: 23059829     DOI: 10.1002/pst.1542

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  8 in total

1.  Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.

Authors:  Giulia Lestini; Cyrielle Dumont; France Mentré
Journal:  Pharm Res       Date:  2015-06-30       Impact factor: 4.200

2.  Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice.

Authors:  Giulia Lestini; France Mentré; Paolo Magni
Journal:  AAPS J       Date:  2016-06-15       Impact factor: 4.009

3.  Experiment design for nonparametric models based on minimizing Bayes Risk: application to voriconazole¹.

Authors:  David S Bayard; Michael Neely
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-12-01       Impact factor: 2.745

4.  A Semi-Infinite Programming based algorithm for determining T-optimum designs for model discrimination.

Authors:  Belmiro P M Duarte; Weng Kee Wong; Anthony C Atkinson
Journal:  J Multivar Anal       Date:  2014-12-11       Impact factor: 1.473

5.  Using Animal Instincts to Design Efficient Biomedical Studies via Particle Swarm Optimization.

Authors:  Jiaheng Qiu; Ray-Bing Chen; Weichung Wang; Weng Kee Wong
Journal:  Swarm Evol Comput       Date:  2014-10-01       Impact factor: 7.177

6.  Optimal Bayesian design for model discrimination via classification.

Authors:  Markus Hainy; David J Price; Olivier Restif; Christopher Drovandi
Journal:  Stat Comput       Date:  2022-02-22       Impact factor: 2.324

7.  A robust design for identification of the Parasite Clearance Estimator.

Authors:  Kris M Jamsen; Stephen B Duffull; Joel Tarning; Ric N Price; Julie A Simpson
Journal:  Malar J       Date:  2013-11-13       Impact factor: 2.979

8.  A design criterion for symmetric model discrimination based on flexible nominal sets.

Authors:  Radoslav Harman; Werner G Müller
Journal:  Biom J       Date:  2020-01-20       Impact factor: 1.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.